AML-MDS 001

Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS (AML-MDS 001)

Arms / Cohorts

Experimental:CD33 FPBMC + Hypomethylating Agent with or without Venetoclax

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.